세계의 알레르기 진단 시장 보고서(2025년)
Allergy Diagnostics Global Market Report 2025
상품코드 : 1821530
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,516,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,419,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,322,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

알레르기 진단 시장 규모는 앞으로 수년간 급성장할 것으로 전망됩니다. 2029년 연평균 복합 성장률(CAGR)은 13.3%로 115억 4,000만 달러로 성장할 것으로 예상됩니다. 예측기간의 성장은 경제 성장, 헬스케어 인프라의 확대, 고령화 사회의 확대, 조기진단과 예방의 중시 등에 기인하고 있습니다. 예측 기간의 주요 동향에는 분자 알레르기 진단, 맞춤형 알레르겐 프로파일, 가정용 알레르기 검사 키트, 인공지능(AI) 통합, 원격 의료, 원격 알레르기 상담 등이 포함됩니다.

향후 5년간의 성장률 13.3%라고 하는 예측은 전회 예측으로부터 0.2%의 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 독일과 덴마크에서 개발된 IgE 면역분석 패널과 피부 프릭 테스트용 추출액의 가격을 상승시켜 알레르기 확인 지연 및 진단 실험실 비용 상승을 초래하여 미국의 면역학적 검사를 저해할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 보다 광범위하게 이어질 수 있습니다.

알레르기 질환의 이환율 증가는 알레르기 진단 시장의 확대를 촉진합니다. 알레르기 질환 증가는 교통 정체 및 산업 배출물 등 다양한 원인으로 인한 환경 오염의 증폭과 관련이 있습니다. 알레르기 반응은 알레르겐에 의해 유발되는 유해한 면역 반응이며, 알레르기성 비염, 음식 알레르기, 피부 알레르기, 천식 등의 증상을 유발합니다. 이러한 증상에 대한 주요 치료법은 알레르겐에 대한 노출을 피하는 것이며 정확한 알레르기 진단은 효과적인 치료에 필수적인 요소입니다. 미국 알레르기 천식 면역학회(American College of Allergy, Asthma, and Immunology: ACAAI)에 따르면 미국에서 알레르기 질환의 유병률은 모든 연령대에서 상당히 높으며 수백만 명이 앓고 있습니다. 천식은 600만 명 이상의 소아를 포함한 약 2,400만 명에, 알레르기는 연간 5,000만 명 이상의 미국인에게 영향을 미칩니다. 알레르기에 의한 경제적 부담은 상당한 것으로, 그 초과액은 약 1,800만 달러에 이릅니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

SHW
영문 목차

영문목차

Allergy diagnostics includes tests and procedures to identify specific allergens, such as foods, pollens, or chemicals, that trigger allergic reactions. The primary objective is to accurately detect allergens, enabling healthcare providers to recommend suitable treatments. This enhances the management of allergic conditions.

The main types of allergy diagnostics tests are in-vivo allergy tests, which are performed on the human body to identify the cause of allergic reactions, and in-vitro allergy tests, which are conducted in laboratories using test tubes and Petri dishes to identify allergy-causing substances. Products in the allergy diagnostics market include consumables, instruments, and luminometers. Allergens are categorized into inhaled allergens, food allergens, and drug allergens. Major end-users of allergy diagnostics include diagnostic laboratories, hospital-based laboratories, and academic and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The allergy diagnostics market research report is one of a series of new reports from The Business Research Company that provides allergy diagnostics market statistics, including allergy diagnostics industry global market size, regional shares, competitors with an allergy diagnostics market share, detailed allergy diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the allergy diagnostics industry. This allergy diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The allergy diagnostics market size has grown rapidly in recent years. It will grow from $6.32 billion in 2024 to $6.99 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to rise in prevalence of allergies, investments in research and development of allergy diagnostics, changing dietary habits and environmental factors, government initiatives, rise in demand for personalized medicine.

The allergy diagnostics market size is expected to see rapid growth in the next few years. It will grow to $11.54 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to economic growth, expanding healthcare infrastructure, expansion of The aging population, greater emphasis on early diagnosis and prevention,. Major trends in the forecast period include molecular allergy diagnostics, customized allergen profiles, allergy testing kits for home use, integration of artificial intelligence (AI), telemedicine and remote allergy consultations.

The forecast of 13.3% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. immunology testing by inflating prices of IgE immunoassay panels and skin prick test extracts developed in Germany and Denmark, resulting in delayed allergy identification and higher diagnostic laboratory costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing incidence of allergic diseases is set to drive the expansion of the allergy diagnostics market. The uptick in allergic disorders is linked to amplified environmental pollution arising from various sources such as heavy traffic and industrial emissions. Allergic reactions are adverse immune responses triggered by allergens, leading to conditions like allergic rhinitis, food allergies, skin allergies, and asthma. The primary remedy for these conditions involves avoiding exposure to the allergen, making precise allergy diagnostics an integral part of effective treatment. As per the American College of Allergy, Asthma, and Immunology (ACAAI), the prevalence of allergic diseases is considerable in the United States across all age groups, affecting millions. Asthma, affecting about 24 million individuals, including over 6 million children, and allergies impacting more than 50 million Americans annually. The economic burden from allergies is substantial, costing about $18 million in excess.

The enhancement of healthcare infrastructure is anticipated to be a driving force behind the growth of the allergy diagnostics market. Healthcare infrastructure encompasses the complete network of healthcare services and resources available in a specific region or country. This infrastructure enables access to specialized allergy clinics, diagnostics facilities, and expert healthcare practitioners skilled in diagnosing allergic conditions. This system ensures timely and accurate evaluations for individuals dealing with allergy-related concerns. As of May 2023, the Office for National Statistics reports a significant increase in healthcare spending in the UK, which saw a real-term expenditure hike of about 13.5% (£32 billion) ($38.78 billion) and a nominal-term increase of roughly 26.8% (£60 billion) ($72.72 billion) compared to 2019. This notable investment in healthcare infrastructure underlines its vital role in fostering the growth of allergy diagnostics.

A recent trend observed in the allergy diagnostics market is the rise in collaborations and partnerships between companies to develop innovative testing techniques or enhance existing methodologies. An example from August 2022 includes LifeMD, a US-based telehealth company, revealing a strategic partnership between its subsidiary, Cleared, and Allergenis, a US-based predictive data analytics company. This collaboration is designed to leverage Cleared's expertise in allergy telehealth services and Allergenis' peanut allergy diagnostic blood test within the direct-to-customer channel. This trend of strategic partnerships is aimed at mutual innovation and improvement of diagnostic solutions in the allergy diagnostics industry.

Major firms within the allergy diagnostics sector are pioneering cutting-edge technologies like an AI-fueled allergy component testing platform to enhance their market position and drive profitability. An AI-powered allergy component testing platform utilizes advanced artificial intelligence to interpret allergy testing outcomes. For example, in May 2023, Metropolis, an India-based pathology lab and diagnostic center, introduced an AI-driven allergy component testing platform capable of identifying various allergens like respiratory, contact, and food-related. This innovative platform yields detailed insights into individual allergy conditions, facilitating more informed clinical decisions through component-resolved diagnostics (CRD) and AI-enabled analysis.

In July 2024, Roche, a Switzerland-based pharmaceutical company, acquired LumiraDx for an undisclosed amount. This acquisition aims to strengthen Roche's diagnostics portfolio by integrating LumiraDx's technologies, significantly improving patient access to diagnostic testing, particularly in primary care settings. LumiraDx is a US-based healthcare company that provides microfluidic immunofluorescence assays.

Major companies operating in the allergy diagnostics market include BioMerieux SA, Danaher Corporation, HOB Biotech Group Corp. Ltd., HYCOR Biomedical, Lincoln Diagnostics Inc., Omega Diagnostics Group PLC., Siemens Healthineers AG, Thermo Fisher Scientific Inc., PerkinElmer Inc., R-Biopharm AG, Alcon Laboratories Inc., Abbott Laboratories, HollisterStier Allergy, NEOGEN Corporation, AESKU.GROUP GmbH, ACON Laboratories Inc., Erba Group, Astra Biotech GmbH, Stallergenes Greer, Diagenics Limited, DST Diagnostische Systeme & Technologien GmbH, HAL Allergy Group, INDOOR Biotechnologies Inc., MacroArray Technologies LLC, Microtest Laboratories Inc., Phadia AB, Quest Diagnostics, Randox Laboratories Ltd., Symbiotix Biotherapies Inc., Eurofins Viracor Inc., VRL Laboratories

North America was the largest region in the allergy diagnostics market in 2024. The regions covered in the allergy diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the allergy diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The allergy diagnostics market includes revenue earned by instruments such as immunoassay analyzers, ELISA analyzers, luminometers, and other instruments that are used to diagnose allergies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Allergy Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on allergy diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for allergy diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The allergy diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Allergy Diagnostics Market Characteristics

3. Allergy Diagnostics Market Trends And Strategies

4. Allergy Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Allergy Diagnostics Growth Analysis And Strategic Analysis Framework

6. Allergy Diagnostics Market Segmentation

7. Allergy Diagnostics Market Regional And Country Analysis

8. Asia-Pacific Allergy Diagnostics Market

9. China Allergy Diagnostics Market

10. India Allergy Diagnostics Market

11. Japan Allergy Diagnostics Market

12. Australia Allergy Diagnostics Market

13. Indonesia Allergy Diagnostics Market

14. South Korea Allergy Diagnostics Market

15. Western Europe Allergy Diagnostics Market

16. UK Allergy Diagnostics Market

17. Germany Allergy Diagnostics Market

18. France Allergy Diagnostics Market

19. Italy Allergy Diagnostics Market

20. Spain Allergy Diagnostics Market

21. Eastern Europe Allergy Diagnostics Market

22. Russia Allergy Diagnostics Market

23. North America Allergy Diagnostics Market

24. USA Allergy Diagnostics Market

25. Canada Allergy Diagnostics Market

26. South America Allergy Diagnostics Market

27. Brazil Allergy Diagnostics Market

28. Middle East Allergy Diagnostics Market

29. Africa Allergy Diagnostics Market

30. Allergy Diagnostics Market Competitive Landscape And Company Profiles

31. Allergy Diagnostics Market Other Major And Innovative Companies

32. Global Allergy Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Allergy Diagnostics Market

34. Recent Developments In The Allergy Diagnostics Market

35. Allergy Diagnostics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기